Zai Lab shareholders approve 2022 Equity Plan and amended Articles for HK dual-primary listing

Zai Lab Ltd

Shareholders approved 2022 Equity Incentive Plan (97,908,743 shares) conditioned on HKEX dual-primary listing becoming effective.
Sixth Amended and Restated Memorandum and Articles of Association approved to reflect HK listing requirements and March 2022 share subdivision.
All twelve director nominees re-elected, including CEO Samantha Du and chairs; advisory vote on exec compensation set for annual frequency.
Ratification of KPMG LLP as independent auditor for FY2022; share issue mandate of up to 20% of issued shares approved.
Plan replaces 2017 and 2015 plans; no new grants under old plans after HK dual-primary listing effective date.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.